College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia.
King Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Neurosurg Rev. 2023 Jul 6;46(1):168. doi: 10.1007/s10143-023-02070-9.
Hemangioblastoma is a rare benign tumor that can affect the central nervous system sporadically or in association with von Hippel-Lindau (VHL) syndrome. Despite the advances in the medical field, hemangioblastoma still has a significant morbidity and mortality burden. This review gathered and analyzed this entity's top one hundred cited articles. The Scopus database was screened using the following keywords ("Hemangioblastoma" OR "Haemangioblastoma" OR "Hemangioblastomata"). The results were sorted by citation count, highest to lowest. Articles discussing hemangioblastoma of the central nervous system were included. Two independent reviewers extracted the article-, author-, and Journal-based data. Articles were classified into four categories: clinical features/ natural history, treatment, histopathology, review, or radiology. The location, brain, spine, or both, and type, sporadic, VHL-associated, or both, were used to classify the articles. The search query resulted in 4023 articles, and the top 100 most cited articles were included. The number of citations totaled 8781, averaging 87.81 CC per article. The included papers were published in 41 different journals between 1952 and 2014 by more than 11 departments from 65 institutions and 16 countries. The number of citations ranged from 46 to 333. The peak publication activity was before the 2000s, contributing to 62% of all articles, and the most prolific decade was 1990-2000, with 37 publications. We conducted a comprehensive bibliometric analysis of data from the most influential publications on central nervous system hemangioblastoma. We identified publication dynamics and research gaps. More high-impact studies are warranted to enhance disease comprehension and management.
血管母细胞瘤是一种罕见的良性肿瘤，可零星发生于中枢神经系统，也可与 von Hippel-Lindau（VHL）综合征相关。尽管医学领域取得了进步，但血管母细胞瘤仍然存在显著的发病率和死亡率负担。本综述收集并分析了该实体排名前 100 的引用文献。使用以下关键词（"Hemangioblastoma" 或 "Haemangioblastoma" 或 "Hemangioblastomata"）在 Scopus 数据库中进行筛选。结果按引用计数从高到低排序。纳入讨论中枢神经系统血管母细胞瘤的文章。两位独立的审查员提取文章、作者和期刊数据。文章分为四类：临床特征/自然史、治疗、组织病理学、综述或放射学。根据位置（脑、脊柱或两者兼有）和类型（散发性、VHL 相关性或两者兼有）对文章进行分类。检索查询得到 4023 篇文章，纳入前 100 篇被引用最多的文章。引用次数总计 8781 次，平均每篇文章 87.81 次。纳入的论文发表于 1952 年至 2014 年之间的 41 种不同期刊，来自 65 个机构和 16 个国家的 11 个以上科室。引用次数范围为 46 至 333。发表高峰期在 21 世纪前十年，占所有文章的 62%，最多产的十年是 1990-2000 年，有 37 篇出版物。我们对中枢神经系统血管母细胞瘤最有影响力的出版物进行了全面的文献计量学分析。我们确定了发表动态和研究差距。需要开展更多高影响力的研究来提高对疾病的认识和管理。
